A Study of LY3439539 in Participants With Alzheimer's Disease

Summary

The purpose of this study is to see how LY3439539 affects certain proteins found in the spinal fluid of participants with Alzheimer's disease. Participation in the study will last approximately 9 months with visits about once a month.

Timeline

Start

2026-05-21

Primary completion

2027-08

Completion

2027-08

Drugs

Indications